Cadila Healthcare receives EIR for Ahmedabad facility

10 Feb 2020 Evaluate

Cadila Healthcare’s topical manufacturing facility located at Ahmedabad, India has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) signifying the successful closure of the audit. The topical manufacturing facility had completed the USFDA audit from December 16, 2019 to December 20, 2019 with zero 483 observations.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×